The US Food and Drug Administration (USFDA) has completed the audit of Dr Reddy’s Laboratories Ltd's Mexico unit.
"The audit of our Active Pharmaceutical Ingredients (API) Cuernavaca plant at Mexico by the USFDA has been completed with zero observations,’’ the Hyderabad-based Dr Reddy’s informed the bourses.
Dr Reddy’s shares ended up by 0.69 per cent at Rs 2,765.10 on the BSE.